share_log

HC Wainwright & Co. Maintains Buy on Galera Therapeutics, Lowers Price Target to $6

Benzinga ·  Mar 22, 2023 06:22

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Galera Therapeutics (NASDAQ:GRTX) with a Buy and lowers the price target from $10 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment